摘要
目的:研究观察咪唑斯汀联合雷尼替丁治疗慢性特发性荨麻疹临床效果。方法:选取81例慢性特发性荨麻疹患者分为两组,对照组患者口服10 mg咪唑斯汀,1次/d;治疗组患者口服10 mg咪唑斯汀,1次/d,口服150 mg的雷尼替丁胶囊,2次/d,两组患者均治疗1个月,对比分析两组患者治疗效果。结果:治疗组总有效率为94.9%;对照组患者总有效率为76.2%。结论:咪唑斯汀与雷尼替丁联合治疗慢性特发性荨麻疹安全有效,并发症较少,具有一定的临床价值,值得推广。
Objective Study and observe the clinical effect of mizolastine joint ranitidine treatment of chronic idiopathic urticaria.Methods To pick up 81 cases of chronic idiopathic urticaria patients were divided into two groups,control group patients were treated with a daily time 10 mg mizolastine;treatment group patients were treated once a day 10 mg mizolastine,oral administration of 150 mg of Raneyfor a small capsule,2 times a day, two groups of patients were treated for one month,comparative analysis of two sets of patient outcomes.Results The total effective rate 94.9%;control group in patients with total effective rate was 76.2%.Conclusion Mizolastine and ranitidine combination therapy of chronic idiopathic urticaria safety, fewer complications,have some clinical value worthy of promotion.
出处
《吉林医学》
CAS
2012年第12期2471-2472,共2页
Jilin Medical Journal
